English

English Chinese Simplified Chinese Traditional French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur

Leave Your Message

Marketing Campaign

News Categories

Featured News

LBT LB-20 Medical Cyclotron Supports Clinical PET Imaging and Radiopharmaceutical Research in Xi’an, China

LBT LB-20 Medical Cyclotron Supports ...

What Makes RDC Development So Challenging? From Molecular Design to Cyclotron Radionuclide Production

What Makes RDC Development So Challen...

Expanding PET Radiopharmaceutical Production in Burkina Faso with an LBT 11 MeV Medical Cyclotron

Expanding PET Radiopharmaceutical Pro...

RDC vs ADC: What Makes Radionuclides a Unique Therapeutic Payload? 🎯 ADC and RDC share a similar idea: use a targeting molecule to find the tumor, then let the payload do the killing. But their thera

RDC vs ADC: What Makes Radionuclides ...

Beyond ¹⁷⁷Lu and ²²⁵Ac: Where Are Next-Generation Therapeutic Radionuclides Heading?

Beyond ¹⁷⁷Lu and ²²⁵Ac: Where Are Nex...

β vs α: Why Are There Two Different Routes in Radionuclide Therapy?

β vs α: Why Are There Two Different R...

Why Do Diagnostic and Therapeutic Radionuclides Need to Be Matched?

Why Do Diagnostic and Therapeutic Rad...

From Imaging to Therapy: How Radioactive Decay Shapes Clinical Use

From Imaging to Therapy: How Radioact...

From Seeing Disease to Treating It: Why Radiopharmaceuticals Matter

From Seeing Disease to Treating It: W...

🧪 When a Pharmaceutical Company Builds Its Own Radionuclide Production Capability

🧪 When a Pharmaceutical Company Build...

0102030405

🚀 Counting down to CMEF 2026 — see you soon in Shanghai!

2026-03-27

The countdown is on. In just a few days, we’ll be in Shanghai for CMEF 2026.

At LBT, everything is set — from system preparation to on-site setup. We’re ready to welcome partners, customers, and industry professionals from around the world.

This year, we’ll be bringing a complete and up-close experience of our technologies, with more opportunities for discussion, exchange, and real conversations.

📍 April 9–12, 2026

📍 National Exhibition and Convention Center (Shanghai)

📍 Booth: Hall 3.1 | 3.1ZD09

If you’re attending CMEF, don’t miss the chance to stop by and connect with us.

See you very soon.